Response: Randomised trial of the effect of a gastrin/CCK2 receptor antagonist on esomeprazole-induced hypergastrinaemia: evidence against rebound hyperacidity

Eur J Clin Pharmacol. 2017 Jul;73(7):925. doi: 10.1007/s00228-017-2241-3. Epub 2017 Apr 1.

Authors

Malcolm Boyce¹, Frans van den Berg², Toni Mitchell², Kate Darwin², Steve Warrington²

Affiliations

¹ Hammersmith Medicines Research, Cumberland Avenue, London, NW10 7EW, UK. mboyce@hmrlondon.com.
² Hammersmith Medicines Research, Cumberland Avenue, London, NW10 7EW, UK.

PMID: 28365794
DOI: 10.1007/s00228-017-2241-3

No abstract available

Publication types

Letter
Comment

MeSH terms

Benzodiazepinones
Esomeprazole
Gastric Acid
Gastrins*
Humans
Receptor, Cholecystokinin B*

Substances

Benzodiazepinones
Gastrins
Receptor, Cholecystokinin B
Esomeprazole